ESC 365 - Predictors of adverse cardiovascular events in patients with truncating variants in the filamin c (flnc) gene.

ESC Premium Access

Predictors of adverse cardiovascular events in patients with truncating variants in the filamin c (flnc) gene.

Session: The potential of genetic testing in dilated cardiomyopathy

Topic: Dilated Cardiomyopathy

Speaker: Doctor M. Akhtar (London, GB)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Majid Akhtar

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

2 presentations

1 follower

4 more presentations in this session

State of the Art - Genetic testing in dilated cardiomyopathy

Speaker: Professor C. Seidman (Boston, US)

Novel insights into desminopathy in the era of next generation sequencing

Speaker: Doctor M. Kubanek (Prague, CZ)

New risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies

Speaker: Doctor K. Wahbi (Paris, FR)

Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Speaker: Professor A. Bondue (Brussels, BE)

Access the full session

The potential of genetic testing in dilated cardiomyopathy

Speakers: Doctor M. Akhtar, Professor C. Seidman, Doctor M. Kubanek, Doctor K. Wahbi, Professor A. Bondue

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources